Secondary hemophagocytic lymphohistiocytosis due to nivolumab/ipilimumab in a renal cell cancer patient—A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Secondary hemophagocytic lymphohistiocytosis due to nivolumab/ipilimumab in a renal cell cancer patient—A case report

Published:2021-12 Issue:12 Volume:9 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Masood Adeel¹²^ORCID,Wahab Ahsan³^ORCID,Clifford Tanya²,Weaver Eric J.²,Ehsan Hamid⁴^ORCID,El Ayass Walid²

Affiliation:

1. Masters of Public Health in Epidemiology at the University of Alabama at Birmingham Alabama USA

2. Tidal Health Peninsula Regional Salisbury Maryland USA

3. Baptist Medical Center South University of Alabama at Birmingham Montgomery Alabama USA

4. Levine Cancer Institute/Atrium Health Charlotte North Carolina USA

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.5184

Reference24 articles.

1. Hemophagocytic lymphohistiocytosis: A diagnostic conundrum

2. Adult haemophagocytic lymphohistiocytosis: a review

3. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation

4. Pembrolizumab (Keytruda)

5. Releasing the Brake on the Immune System: Ipilimumab in Melanoma and Other Tumors

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study;Frontiers in Oncology;2024-06-11

2. Clinical characterization of hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors: a review of published cases;Hematology;2024-04-12

3. Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review;BMC Geriatrics;2024-01-08

4. Miscellaneous annular diseases;Clinics in Dermatology;2023-05

5. Hemophagocytic Lymphohistiocytosis Associated with Immunological Checkpoint Inhibitors: A Pharmacovigilance Study;Journal of Clinical Medicine;2023-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3